mTOR and cancer: many loops in one pathway
The mammalian target of rapamycin (mTOR) is a master regulator of cell growth and division that responds to a variety of stimuli, including nutrient, energy, and growth factors. In the last years, a significant number of pieces have been added to the puzzle of how mTOR coordinates and executes its f...
Main Authors: | Efeyan, Alejo (Contributor), Sabatini, David (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology (Contributor), Whitehead Institute for Biomedical Research (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Sabatini, David M. (Contributor) |
Format: | Article |
Language: | English |
Published: |
Elsevier,
2012-11-01T16:42:06Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
mTOR: from growth signal integration to cancer, diabetes and ageing
by: Zoncu, Roberto, et al.
Published: (2012) -
The mTOR–Autophagy Axis and the Control of Metabolism
by: Nerea Deleyto-Seldas, et al.
Published: (2021-07-01) -
mTOR signaling pathway and mTOR inhibitors in the treatment of cancer
by: Mehmet Küçüköner, et al.
Published: (2013-03-01) -
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
by: Zhilin Zou, et al.
Published: (2020-03-01) -
mTOR Pathways in Cancer and Autophagy
by: Mathieu Paquette, et al.
Published: (2018-01-01)